GSK Secures FDA Approval for New Blood Cancer Treatment bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
GSK s vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people 60 and older, as the drugmaker races against Pfizer to bring to market the first vaccine for RSV.
Bluebell wants to appoint a board representative for A-class shareholders who have weaker voting rights than the company’s B-class shares controlled by chairman Johann Rupert.